Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02605187 · ClinicalTrials.gov registry record · NA
Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT02605187: Completed NA study, sponsored by Stanford University.
NCT02605187 is a NA study that has completed, run by Stanford University. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02605187, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
The ability to predict pain and then apply modified treatment protocols has been limited. Current practice is for physicians to select standard post-operative pain treatment protocols without patient consultation. This study hopes to determine if patient's involvement in analgesic drug/dosage selection can optimize pain relief while minimizing related side effects. This could result in a more patient-centered care model and individualized perioperative analgesic treatment protocols based on patient's preferences, needs and expectations.
Interventions
- DRUG Acetaminophen
- DRUG Ibuprofen
- DRUG Gabapentin
- OTHER No choice given
- OTHER Choice given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-05-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02605187
The ClinicalTrials.gov registry entry for NCT02605187 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.
NCT02605187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02605187 about?
NCT02605187 is a clinical study titled "Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management". The ability to predict pain and then apply modified treatment protocols has been limited. Current practice is for physicians to select standard post-operative pain treatment protocols without patient consultation. This study hopes to determine if patient's involvement in analgesic drug/dosage select...
What is the current status of trial NCT02605187?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2015-11. Estimated completion is 2017-05-22.
What interventions are being tested in trial NCT02605187?
The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG), Gabapentin (DRUG), No choice given (OTHER), Choice given (OTHER).
Who is sponsoring clinical trial NCT02605187?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.